Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.
Current therapy for toxoplasmosis with a synergistic combination of pyrimethamine plus sulfadiazine or pyrimethamine plus clindamycin is not always efficacious and is frequently discontinued due to intolerable toxic effects in immunocompromised individuals, particularly those with AIDS. Trovafloxaci...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1997
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9145840/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.5.893 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
